Releases
Current Releases
Human Genome Sciences et GlaxoSmithKline annoncent des résultats positifs de phase III du BENLYSTA(TM) pour le lupus érythémateux disséminé
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
view complete archive
02/09/10 20:03 ET Quotes Delayed 20 minutes.
Current Releases
view complete archive